COBDEN RESEARCH LIMITED Leading authority on the production and use of essential fatty acids in human nutrition |
|
Our Services CLINICAL TRIALS |
Clinical Trials For 10 years Peter Clough was responsible for managing the clinical trials programme for Efamol Ltd., a UK-based manufacturer of nutritional supplements. This involved co-ordinating activities with research groups, universities, hospitals and other institutions, working with essential fatty acids internationally in the UK, Europe, Australia, New Zealand, and Singapore. These projects have been either directly funded (wholly or partly) by Efamol Ltd, or by national research councils or government agencies. During that time he has had an active involvement in approximately 20 projects ranging in size from 50 subjects to 2500 subjects. Clinical areas of interest have included maternal and infant nutrition, child development and learning, memory and cognitive function in young and elderly adults, sickle cell disease and skin health. Peter Clough is therefore well prepared to offer advice and assistance in the following areas:
Recent clinical trials on which Peter Clough has acted as an advisor or co-ordinator include:
Published Trial Reports Acknowledgment (personal or corporate) of contribution to published clinical trials in which Peter Clough has been involved can be found in : Al-Ghannami SS, et al. Jackson PA, et al. Strike SC, et al. Daak AA, et al. Daak AA, Ghebremeskel K, Hassan Z, Attallah B, Azan HH, Elbashir MI, Crawford M Long S-J and Benton D Stonehouse W, Conlon C, Podd J, Hill SR, Minihane AM, Haskell C, Kennedy D Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, Makrides M Makrides M, Gibson R, McPhee A, Yelland L, Quinlivan J et al. Zaalberg A et al. Muggli R Meguid NA et al. Geppert J et al. Morse NL and Clough P Muggli R |